Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 2, 2011, Pages 353-359

  Varlotto, John M ^a   Medford Davis, Laura Nyshel ^b   Recht, Abram ^b,c   Flickinger, John C ^d   Schaefer, Eric ^e   Decamp, Malcolm M ^f  

^a PENN STATE CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Lung cancer; N1 nodal involvement; Pattern of recurrence; Surgical resection

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASES; PATIENT MONITORING; RADIOTHERAPY;

ADJUVANT CHEMOTHERAPY; COX PROPORTIONAL HAZARD MODEL; LUNG CANCER; N1 NODAL INVOLVEMENT; NON SMALL CELL LUNG CANCER; PATTERN OF RECURRENCE; POSTOPERATIVE RADIOTHERAPY; SURGICAL RESECTION;

FAILURE ANALYSIS;

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE;

EID: 80052820472     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.022     Document Type: Article

References (23)

1. International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer N Engl J Med 350 2004 351 360
2. T. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer N Engl J Med 352 2005 2589 2597 (Pubitemid 41007845)
3. J. Douillard, R. Rosell, and M. Delena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial Lancet Oncol 7 2006 719 727 (Pubitemid 44283661)
4. G.M. Strauss, J.E. Herdon, and M.A. Maddaus Adjuvant chemotherapy in Stage IB non-small cell lung cancer: Update of CALGB protocol 9633(abstract 7007) J Clin Oncol 24 18S 2006 365S
5. G.M. Strauss, J.E. Herndon, and M.A. Maddaus Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups J Clin Oncol 26 2008 5043 5051
6. R. Arriagada, A. Dunant, and J.-P. Pignon Long-term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer J Clin Oncol 28 2010 35 42
7. C.A. Butts, K. Ding, and L. Seymour Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small cell lung cancer: Updated survival analysis of JBR-10 J Clin Oncol 28 2010 29 34
8. J.M. Varlotto, A. Recht, and J.C. Flickinger Factors associated with local and distant recurrence and survival in patients with resected non-small cell lung cancer Cancer 115 2009 1059 1069
9. J.M. Varlotto, A. Recht, and J.C. Flickinger Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically-resected Stage I non-small cell lung cancer Cancer 116 2010 2390 2400
10. Surveillance, Epidemiology, and End Results (SEER) program public-use data (1973-2006), National Cancer Institute, DCCPS, Surveillance Research Statistics Branch. Available at: http://seer.cancer.gov/publicdata/. Accessed October 3, 2009.
11. T. LeChevalier, D. Brisgand, and J.Y. Douillard Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients J Clin Oncol 12 1994 360 367
12. R. Rosell, U. Gatzemeier, and D.C. Betticher Phase III randomized trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small cell lung cancer: A cooperative multinational trial Ann Oncol 13 2002 1539 1549 (Pubitemid 35331451)
13. A. Ardizzoni, L. Boni, and M. Tiseo Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer: An individual patient data meta-analysis J Natl Cancer Inst 99 2007 847 857
14. F. Grossi, M. Aita, and C. Defferrari Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: A meta-analytical approach Oncologist 14 2009 497 510
15. J.Y. Douillard, H. Tribodet, and D. Aubert Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: Subgroup analysis of the lung adjuvant cisplatin evaluation J Thorac Oncol 5 2010 220 228
16. PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials Lancet 352 1998 257 263
17. J.Y. Douillard, R. Rosell, and M. De Lena Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial Int J Radiat Oncol Biol Phys 72 2008 695 701
18. H.A. Wakelee, P. Stephenson, and S.M. Keller Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590 Lung Cancer 48 2005 389 397 (Pubitemid 40693625)
19. L. Trodella, P. Granone, and S. Valente Adjuvant radiotherapy in non-small cell lung cancer with pathological Stage I: Definitive results of a phase III randomized trial Radiother Oncol 62 2002 11 19 (Pubitemid 34121945)
20. J. Deslauriers, J. Grégoire, and L.F. Jacques Sleeve lobectomy versus pneumonectomy for lung cancer: A comparative analysis of survival and sites or recurrences Ann Thorac Surg 77 2004 1152 1156 (Pubitemid 38452336)
21. J.M. Brechot, S. Chevret, and M.C. Charpentier Blood vessel and lymphatic vessel invasion in resected non-small cell lung carcinoma: Correlation with TNM stage and disease free and overall survival Cancer 78 1996 2111 2118 (Pubitemid 26367603)
22. C.F. Mountain New prognostic factors in lung cancer: Biologic prophets of cancer cell aggression Chest 108 1995 246 254
23. A.B. de la Rivire, and H.R. Elbers Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA Chest 117 2000 374 379 (Pubitemid 30111585)